Everest Organics Limited (BOM:524790)
286.95
-2.05 (-0.71%)
At close: Aug 17, 2026
Everest Organics Revenue
Everest Organics had revenue of 488.50M INR in the quarter ending June 30, 2026, a decrease of -10.14%. This brings the company's revenue in the last twelve months to 1.92B, up 5.58% year-over-year. In the fiscal year ending March 31, 2026, Everest Organics had annual revenue of 1.97B with 23.41% growth.
Revenue (ttm)
1.92B
Revenue Growth
+5.58%
P/S Ratio
1.45
Revenue / Employee
5.41M
Employees
355
Market Cap
2.79B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 1.97B | 374.51M | 23.41% |
| Mar 31, 2025 | 1.60B | -380.70M | -19.23% |
| Mar 31, 2024 | 1.98B | 141.55M | 7.70% |
| Mar 31, 2023 | 1.84B | -177.25M | -8.79% |
| Mar 31, 2022 | 2.02B | 195.19M | 10.72% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Medico Remedies | 2.38B |
| Medicamen Biotech | 2.06B |
| Ambalal Sarabhai Enterprises | 1.99B |
| Gennex Laboratories | 1.78B |
| Astonea Labs | 1.48B |
| Trident Lifeline | 1.39B |
| Oxygenta Pharmaceutical | 1.35B |
| BDH Industries | 996.09M |